{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T13:54:14Z","timestamp":1779890054727,"version":"3.53.1"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2018,1,9]],"date-time":"2018-01-09T00:00:00Z","timestamp":1515456000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1007\/s11060-017-2740-1","type":"journal-article","created":{"date-parts":[[2018,1,9]],"date-time":"2018-01-09T10:25:23Z","timestamp":1515493523000},"page":"543-549","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Mid-term prognosis of non-functioning pituitary adenomas with high proliferative potential: really an aggressive variant?"],"prefix":"10.1007","volume":"137","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6834-6468","authenticated-orcid":false,"given":"Yoshikazu","family":"Ogawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidefumi","family":"Jokura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuniyasu","family":"Niizuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teiji","family":"Tominaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,1,9]]},"reference":[{"key":"2740_CR1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0037-1600515","author":"T Endo","year":"2017","unstructured":"Endo T, Ogawa Y, Watanabe M, Tominaga T (2017) A case of pituitary carcinoma initially diagnosed as an ectopic growth hormone producing pituitary adenoma with a high Ki-67 labeling index. J Neurol Surg A. https:\/\/doi.org\/10.1055\/s-0037-1600515","journal-title":"J Neurol Surg A"},{"key":"2740_CR2","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1530\/eje.1.02268","volume":"155","author":"M Kars","year":"2006","unstructured":"Kars M, Roelfsema F, Romijn JA, Pereira AM (2006) Malignant prolactinoma: case report and review of the literature. Eur J Endocrinol 155:523\u2013534","journal-title":"Eur J Endocrinol"},{"key":"2740_CR3","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1111\/j.1365-2265.1994.tb02797.x","volume":"41","author":"A Levy","year":"1994","unstructured":"Levy A, Hall L, Yeudall WA, Lightman SL (1994) P53 gene mutations in pituitary adenomas: rare events. Clin Endocrinol 41:809\u2013814","journal-title":"Clin Endocrinol"},{"key":"2740_CR4","first-page":"93","volume":"27","author":"M Mittelbronn","year":"2006","unstructured":"Mittelbronn M, Meyermann R, Honoegger J (2006) Atypical pituitary adenoma exhibiting densely secretory granules and basophilia without hormone production. Neuro Endocrinol Lett 27:93\u201396","journal-title":"Neuro Endocrinol Lett"},{"key":"2740_CR5","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s11060-007-9492-2","volume":"87","author":"Y Ogawa","year":"2008","unstructured":"Ogawa Y, Tominaga T (2008) A case of atypical thyrotroph cell adenoma, which re-grew within 3 months after surgery and required multimodal treatment. J Neurooncol 87:91\u201395","journal-title":"J Neurooncol"},{"key":"2740_CR6","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/BF03346512","volume":"32","author":"Y Ogawa","year":"2009","unstructured":"Ogawa Y, Ikeda H, Tominaga T (2009) Clinicopathological study of prognostic factors in patients with pituitary adenomas and Ki-67 labeling index of more than 3%. J Endocrinol Invest 32:581\u2013584","journal-title":"J Endocrinol Invest"},{"key":"2740_CR7","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1007\/s12022-010-9110-2","volume":"21","author":"Y Ogawa","year":"2010","unstructured":"Ogawa Y, Watanabe M, Tominaga T (2010) Somatostatin-producing atypical null cell adenoma manifesting as severe hypopituitarism and rapid deterioration\u2014case report. Endocr Pathol 21:130\u2013134","journal-title":"Endocr Pathol"},{"key":"2740_CR8","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1530\/eje.1.02326","volume":"156","author":"W Saeger","year":"2007","unstructured":"Saeger W, Ludecke DK, Buchfelder M, Fahlbusch R, Quabbe HJ, Petersenn S (2007) Pathohistological classification of pituitary tumors: 10 years of experience with the German Pituitary Tumor Registry. Eur J Endocrinol 156:203\u2013216","journal-title":"Eur J Endocrinol"},{"key":"2740_CR9","first-page":"1066","volume":"56","author":"BW Scheithauer","year":"2005","unstructured":"Scheithauer BW, Kurtkaya-Yapicier O, Kovacs KT, Loung WF Jr, Lloyd RV (2005) Pituitary carcinoma: a clinicopathological review. Neurosurgery 56:1066\u20131074","journal-title":"Neurosurgery"},{"key":"2740_CR10","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1227\/01.NEU.0000223437.51435.6E","volume":"59","author":"BW Scheithauer","year":"2006","unstructured":"Scheithauer BW, Gaffey TA, Lloyd RV, Sebo TJ, Kovacs KT, Horvath E et al (2006) Pathobiology of pituitary adenomas and carcinomas. Neurosurgery 59:341\u2013353","journal-title":"Neurosurgery"},{"key":"2740_CR11","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1097\/00006123-199601000-00024","volume":"38","author":"K Thapar","year":"1996","unstructured":"Thapar K, Kovacs K, Scheithauer BW, Stefaneanu L, Horvath E, Pernicone PJ et al (1996) Proliferative activity and invasiveness among pituitary adenomas and carcinomas: an analysis using the MIB-1 antibody. Neurosurgery 38:99\u2013107","journal-title":"Neurosurgery"},{"key":"2740_CR12","first-page":"10","volume-title":"WHO classification of tumours. Pathology and genetics: tumours of endocrine organs","author":"RV Lloyd","year":"2004","unstructured":"Lloyd RV, Kovacs K, Young WF Jr et al (2004) Pituitary tumours: introduction. In: DeLellis RA, Lloyd RV, Heitz PU, Eng C (eds) WHO classification of tumours. Pathology and genetics: tumours of endocrine organs. IARC Press, Lyon, pp\u00a010\u201313"},{"key":"2740_CR13","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1385\/ENDO:28:1:027","volume":"28","author":"G Kontogeorgos","year":"2005","unstructured":"Kontogeorgos G (2005) Classification and pathology of pituitary tumors. Endocrine 28:27\u201335","journal-title":"Endocrine"},{"key":"2740_CR14","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1159\/000095526","volume":"83","author":"G Kontogeorgos","year":"2006","unstructured":"Kontogeorgos G (2006) Predictive markers of pituitary adenoma behavior. Neuroendocrinology 83:179\u2013188","journal-title":"Neuroendocrinology"},{"key":"2740_CR15","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1227\/00006123-199604000-00027","volume":"38","author":"K Thapar","year":"1996","unstructured":"Thapar K, Scheithauer BW, Kovacs K, Pernicone PJ, Laws ER Jr (1996) P53 expression in pituitary adenomas and carcinomas: correlation with invasiveness and tumor growth fractions. Neurosurgery 38:765\u2013771","journal-title":"Neurosurgery"},{"key":"2740_CR16","doi-asserted-by":"crossref","first-page":"3089","DOI":"10.1210\/jc.2004-2231","volume":"90","author":"GA Kaltsas","year":"2005","unstructured":"Kaltsas GA, Nomikos P, Kontogeorgos G, Buchfelder M, Grossman AB (2005) Clinical review: diagnosis and management of pituitary carcinomas. J Clin Endocrinol Metab 90:3089\u20133099","journal-title":"J Clin Endocrinol Metab"},{"key":"2740_CR17","doi-asserted-by":"crossref","first-page":"336","DOI":"10.3171\/2010.8.JNS10290","volume":"114","author":"G Zada","year":"2011","unstructured":"Zada G, Woodmansee WW, Ramkissoon S, Amadio J, Nose V, Laws ER Jr (2011) Atypical pituitary adenomas: incidence, clinical characteristics, and implications. J Neurosurg 114:336\u2013344","journal-title":"J Neurosurg"},{"key":"2740_CR18","doi-asserted-by":"publisher","DOI":"10.3171\/2016.12.JNS162126","author":"MJ Rutkowski","year":"2017","unstructured":"Rutkowski MJ, Alward RM, Chen R, Wagner J, Jahngiri A, Southwell DG et al (2017) Atypical pituitary adenoma, a clinicopathological case series. J Neurosurg. https:\/\/doi.org\/10.3171\/2016.12.JNS162126","journal-title":"J Neurosurg"},{"key":"2740_CR19","first-page":"12","volume-title":"WHO classification of tumours: tumours of endocrine organs","author":"RV Lloyd","year":"2017","unstructured":"Lloyd RV, Osamura RY, Kl\u00f6ppel G, Rosai J (2017) Tumours od the pituitary gland: introduction. In: Osamura RY, Lopes MBS, Grossman A, Kontogeorgos G, Trouillas J (eds) WHO classification of tumours: tumours of endocrine organs. IARC Press, Lyon, pp\u00a012\u201318"},{"key":"2740_CR20","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1161\/01.STR.0000198806.67472.5c","volume":"37","author":"HB Huttner","year":"2006","unstructured":"Huttner HB, Steiner T, Hartmann M, Kohrmann M, Juettler E, Mueller S et al (2006) Comparison of ABC\/2 estimation technique to computer-assisted planimetric analysis in warfarin-related intracerebral parenchymal hemorrhage. Stroke 37:404\u2013408","journal-title":"Stroke"},{"key":"2740_CR21","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1161\/01.STR.27.8.1304","volume":"27","author":"RU Kothari","year":"1996","unstructured":"Kothari RU, Brott T, Broderick J, Barsan WG, Sauerbeck LR, Zuccarello M et al (1996) The ABCs of measuring intracerebral hemorrhage volumes. Stroke 27:1304\u20131305","journal-title":"Stroke"},{"key":"2740_CR22","doi-asserted-by":"crossref","first-page":"884","DOI":"10.3171\/jns.2006.104.6.884","volume":"104","author":"K Arita","year":"2006","unstructured":"Arita K, Tominaga A, Sugiyama K, Eguchi K, Iida K, Sumida M et al (2006) Natural course of incidentally found nonfunctioning pituitary adenoma, with special reference to pituitary apoplexy during follow-up examination. J Neurosurg 104:884\u2013891","journal-title":"J Neurosurg"},{"key":"2740_CR23","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1530\/eje.0.1490123","volume":"149","author":"N Sanno","year":"2003","unstructured":"Sanno N, Oyama K, Tahara S, Teramoto A, Kato Y (2003) A survey of pituitary incidentaloma in Japan. Eur J Endocrinol 149:123\u2013127","journal-title":"Eur J Endocrinol"},{"key":"2740_CR24","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1111\/j.1365-2265.1993.tb02137.x","volume":"38","author":"M Brada","year":"1993","unstructured":"Brada M, Rajan B, Traish D, Ashley S, Holmes-Sellors PJ, Nussey S et al (1993) The long-term efficacy of conservative surgery and radiotherapy in the control of pituitary adenomas. Clin Endocrinol 38:571\u2013578","journal-title":"Clin Endocrinol"},{"key":"2740_CR25","doi-asserted-by":"crossref","first-page":"S90","DOI":"10.1016\/j.canrad.2012.01.004","volume":"16 Suppl","author":"ME Chand-Fouche","year":"2012","unstructured":"Chand-Fouche ME, Colin P, Bondiau PY (2012) Pituitary adenomas: multimodal management and modern irradiation techniques [in French]. Cancer Radiother 16 Suppl:S90\u2013S100","journal-title":"Cancer Radiother"},{"key":"2740_CR26","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1530\/EJE-14-0872","volume":"172","author":"G Minniti","year":"2015","unstructured":"Minniti G, Scaringi C, Poggi M, Jaffrain Rea ML, Trillo G, Esposito V et al (2015) Fractionated stereotactic radiotherapy for large and invasive non-functioning pituitary adenomas: long-term clinical outcomes and volumetric MRI assessment of tumor response. Eur J Endocrinol 172:433\u2013441","journal-title":"Eur J Endocrinol"},{"key":"2740_CR27","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.jocn.2011.07.025","volume":"19","author":"PJ Wilson","year":"2012","unstructured":"Wilson PJ, De-Loyde KJ, Williams JR, Smee RI (2012) A single center\u2019s experience of stereotactic radiosurgery and radiotherapy for non-functioning pituitary adenomas with the Linear Accelerator (Linac). J Clin Neurosci 19:370\u2013374","journal-title":"J Clin Neurosci"},{"key":"2740_CR28","doi-asserted-by":"crossref","first-page":"446","DOI":"10.3171\/2013.3.JNS12766","volume":"119","author":"JP Sheehan","year":"2013","unstructured":"Sheehan JP, Starke RM, Mathieu D, Young B, Sneed PK, Chiang VL et al (2013) Gamma knife radiosurgery for the management of nonfunctioning pituitary adenomas: a multicenter study. J Neurosurg 119:446\u2013456","journal-title":"J Neurosurg"},{"key":"2740_CR29","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1002\/cncr.22860","volume":"100","author":"DS Kong","year":"2007","unstructured":"Kong DS, Lee JI, Lim DH, Kim KW, Shin HJ, Nam DH et al (2007) The efficacy of fractionated radiotherapy and stereotactic radiosurgery for pituitary adenomas: long-term results of 125 consecutive patients treated in a single institution. Cancer 100:854\u2013860","journal-title":"Cancer"},{"key":"2740_CR30","first-page":"188","volume":"3","author":"Y Ji","year":"2016","unstructured":"Ji Y, Vogel RI, Lou E (2016) Temozolomide treatment of pituitary carcinomas and atypical adenomas: systemic review of case reports. Neurooncol Pract 3:188\u2013195","journal-title":"Neurooncol Pract"},{"key":"2740_CR31","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/S1470-2045(06)70728-8","volume":"7","author":"S Lim","year":"2006","unstructured":"Lim S, Shahinian H, Maya MM et al Yong W, Heaney AP (2006) Temozolomide: a novel treatment for pituitary carcinoma. Lancet Oncol 7:518\u2013520","journal-title":"Lancet Oncol"},{"key":"2740_CR32","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1007\/s11060-015-1991-y","volume":"126","author":"M Losa","year":"2016","unstructured":"Losa M, Bogazzi F, Cannavo S, Ceccato F, Curto L, De Marinis L et al (2016) Temozolomide therapy in patients with aggressive pituitary adenomas or carcinomas. J Neurooncol 126:519\u2013525","journal-title":"J Neurooncol"},{"key":"2740_CR33","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1111\/j.1365-2265.2006.02653.x","volume":"65","author":"LV Syro","year":"2006","unstructured":"Syro LV, Uribe H, Penagos LC, Ortiz LD, Fadul CE, Horvath E et al (2006) Antitumour effects of temozolomide in a man with a large, invasive prolactin-producing pituitary neoplasm. Clin Endocrinol 65:552\u2013553","journal-title":"Clin Endocrinol"},{"key":"2740_CR34","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1007\/s11102-015-0694-x","volume":"19","author":"M Campdera","year":"2016","unstructured":"Campdera M, Palacios N, Aller J, Magallon R, Martin P, Saucedo G et al (2016) Temozolomide for aggressive ACTH pituitary tumors: failure of a second course of treatment. Pituitary 19:158\u2013166","journal-title":"Pituitary"},{"key":"2740_CR35","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1210\/jc.2012-2924","volume":"98","author":"T Hirohata","year":"2013","unstructured":"Hirohata T, Asano K, Ogawa Y, Takano S, Amano K, Isozaki O et al (2013) DNA mismatch repair protein (MSH6) correlated with the responses of atypical pituitary adenomas and pituitary carcinomas to temozolomide; the national cooperative study by the Japan Society for Hypothalamic and Pituitary Tumors. J Clin Endocrinol Metab 98:1130\u20131136","journal-title":"J Clin Endocrinol Metab"},{"key":"2740_CR36","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s00401-007-0279-5","volume":"115","author":"K Kovacs","year":"2008","unstructured":"Kovacs K, Scheithauer BW, Lombardero M, McLendon RE, Syro LV, Uribe H et al (2008) MGMT immunoexpression predicts responsiveness of pituitary tumors to temozolomide therapy. Acta Neuropathol 115:261\u2013262","journal-title":"Acta Neuropathol"},{"key":"2740_CR37","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s12094-015-1381-0","volume":"18","author":"S Trabelsi","year":"2016","unstructured":"Trabelsi S, Mama N, Ladib M, Karmeni N, Haddaji Mastouri M, Chourabi M et al (2016) MGMT methylation assessment in glioblastoma: MS-MLPA versus human methylation 450K beadchip array and immunohistochemistry. Clin Transl Oncol 18:391\u2013397","journal-title":"Clin Transl Oncol"},{"key":"2740_CR38","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.clineuro.2016.07.013","volume":"148","author":"Y Ogawa","year":"2016","unstructured":"Ogawa Y, Niizuma K, Mugikura S, Tominaga T (2016) Ischemic pituitary adenoma apoplexy\u2014clinical appearance and prognosis after surgical intervention. Clin Neurol Neurosurg 148:142\u2013146","journal-title":"Clin Neurol Neurosurg"},{"key":"2740_CR39","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.3171\/2014.10.JNS141720","volume":"122","author":"EH Oldfield","year":"2015","unstructured":"Oldfield EH, Merrill MJ (2015) Apoplexy of pituitary adenomas: the perfect storm. J Neurosurg 122:1444\u20131449","journal-title":"J Neurosurg"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11060-017-2740-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-017-2740-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-017-2740-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,4,26]],"date-time":"2018-04-26T10:52:54Z","timestamp":1524739974000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11060-017-2740-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,9]]},"references-count":39,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,5]]}},"alternative-id":["2740"],"URL":"https:\/\/doi.org\/10.1007\/s11060-017-2740-1","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1,9]]}}}